Theranostic strategies in sarcoma: preliminary clinical evidence

Luca Filippi,Cristina Ferrari,Giuseppe Rubini
DOI: https://doi.org/10.1080/13543784.2024.2414119
2024-10-10
Expert Opinion on Investigational Drugs
Abstract:Introduction Sarcomas encompass a highly diverse range of malignancies, characterized by varied morphological and molecular profiles. Treatment options in case of therapy-refractory or advanced disease are limited. In this context, theranostics emerges as an innovative platform seamlessly integrating diagnosis and therapy, offering promising prospects.
pharmacology & pharmacy
What problem does this paper attempt to address?